NM heute noch unter 1100 und morgen ...

bzw. am Montag unter 1000 ...
das nennt man auch galoppierente Schwinsucht ...
lol

haut weg dire Scheisse ... alles muss raus ..
ob ihr wollt oder nicht ...

solong best invest

LALA !!!

realtime.bigcharts.com/...tyle=2003&size=1&mocktick=1" style="max-width:560px" />

Float: 15.08M (Institutions1: 52.80%) 2$ monday after institution selloff


Shares Outstanding5: 16.02M
Float: 15.08M
% Held by Insiders1: 4.38%
% Held by Institutions1: 52.80%
Shares Short (as of May 28, 2010)3: 44.58K
Short Ratio (as of May 28, 2010)3: 0.80
Short % of Float (as of May 28, 2010)3: N/A

ih.advfn.com/...d=staticchart&s=N%5ENMTI&p=5&t=15" style="max-width:560px" />

realtime.bigcharts.com/...tyle=2003&size=1&mocktick=1" style="max-width:560px" />

hab schon 3x gekauft...heute !

Posted by: sigsmoke    Date: Thursday, June 17, 2010 11:06:49 PM  
In reply to: momentum74 who wrote msg# 32  Post # of 46      

NMTI has a float of only 15.32M of which 59% of shares are held by institutions, mutual funds, and insiders. That leaves approx. 6M shares for retail. finance.yahoo.com/q/mh?s=NMTI+Major+Holders

The news posted today was not all that bad IMO and NMTI has many other products in the pipeline along with ongoing clinical studies. I can see this jumping back up rather quickly from where it closed today. The AH trading being an indication with over 1M shares traded and a 20% recovery.

I think just buying pressure tomorrow from day/swing traders could move this to the .80-1.00 easily.

Hold even longer and you can reap the rewards of some positive PR's that will be made when NMTI's RT2 Delivery System is launched throughout Europe in the next few months.


investorshub.advfn.com/boards/read_msg.aspx?message_id=51434617

Nmt Medical Inc. (MM (NASDAQ:NMTI)
Last Price (USD) $0.7409
Change  0.1809 (32.30%)
Bid 0.7409
Ask 0.76
Volume 7,924,560
Days Range 0.6199 - 0.8399
Last Trade 6/18/2010 12:58:33 PM

10mill cash 15 mill shares...

seekingalpha.com/instablog/...versold-after-closure-trial-data

Dieser Hotstock wurde heute vor Handelsbeginn von den HH-Analysten als kurz-bis mittelfristig interessanter Kandidat empfohlen.
Hier die Präsentation!

"NMTI Hot Stock
NMTI - US6292941092

stockcharts.com/h-sc/ui?s=nmti

NMTI hatte gestern 15 Minuten vor Handelsschluss diese PR veröffentlicht, in der bekannt gegeben wurde, dass eine medizinische Testreihe zu "CLOSURE I PFO/Stroke" nicht komplett bis zum Ende durchgeführt werden konnte:
finance.yahoo.com/news/...unces-bw-153973274.html?x=0&.v=1

"The preliminary results of CLOSURE I data analysis indicate that the trial did not achieve its primary endpoint: to demonstrate that treatment by device closure with the STARFlex® technology is superior to the current best medical therapy for preventing recurrent strokes and TIAs. However, the preliminary results indicate that closure with STARFlex® provided a small, but not statistically significant, benefit over current best medical therapy."

Die Folge war ein urplötzlicher Selloff unter Rekordvolumen (4,065,224 shares) - die Aktie schloss -78% auf $0,58.

NMTI hat zusätzlich einige andere klinische Studien in der Pipeline, die Potenzial für zukünftig positive News bieten - hier eine Übersicht:
www.snl.com/IRWebLinkX/GenPage.aspx?IID=4148066&GKP=202520

Zudem ist die Aktienstruktur für einen NASDAQ-stock sehr attraktiv:
A/S: 30,000,000 shares
O/S: 16,058,319 shares (31.03.2010)

Kurzfristig kann es noch zu weiteren Kursverlusten kommen - mittelfristig aber sehen wir hier spekulativ interessantes Reboundpotenzial!

NMTI ist auch in Frankfurt handelbar - dort fehlt es aber meist an relvantem Volumen, daher sollten Spekulationswillige den US-Börsenplatz bevorzugen."

http://www.snl.com/IRWebLinkX/GenPage.aspx?IID=4148066&GKP=202520

bigcharts.marketwatch.com/charts/...;rand=1762&mocktick=1" style="max-width:560px" />

bigcharts.marketwatch.com/charts/...p;rand=1762&mocktick=1

www.finviz.com/...hx?t=NMTI&ty=c&ta=1&p=d&s=l" style="max-width:560px" />

What comes down goes up !

In addition, we should note that the results of CLOSURE I have no impact on the status of our current FDA and CE Mark approvals for ventricular septal defect (VSD) and atrial level shunt patients

 

#000000 1px solid">Trademark	#000000 1px solid">	#000000 1px solid">Jurisdiction	#000000 1px solid">	#000000 1px solid">Status	#000000 1px solid">	#000000 1px solid">Renewal Date
At The Heart of Brain Attacks™		Canada		Pending		—
At The Heart of Brain Attacks®		European Community		Registered		Sep 2015
At The Heart of Brain Attacks™		United States		Allowed		—
BioSTAR®		Canada		Registered		Jun 2024
BioSTAR®		European Community		Registered		Apr 2014
BioSTAR®		Japan		Registered		Oct 2015
BioSTAR®		United States		Registered		Jun 2016
BioTREK™		Canada		Allowed		—
BioTREK™		European Community		Pending		—
BioTREK®		Japan		Registered		Feb 2016
BioTREK™		United States		Pending		—
CardioSEAL®		United States		Registered		Jan 2018
Gator™		Canada		Pending		—
Gator®		European Community		Registered		Apr 2014
Gator®		Japan		Registered		Sep 2017
Gator™		United States		Allowed		—
NMT Medical®		Canada		Registered		Jan 2018
NMT Medical®		United States		Registered		Apr 2011
Rapid Transport		European Community		Registered		Aug 2013
STARFlex®		Canada		Registered		Sep 2020
STARFlex®		European Community		Registered		Feb 2011
STARFlex®		Japan		Registered		Jun 2014
STARFlex®		United States		Registered		Aug 2012

In addition, we are the exclusive licensee within specific fields of use to several technologies. We are the exclusive licensee under certain patents, expiring from 2012 to 2015, relating to the CardioSEAL®, STARFlex®, and BioSTAR® cardiac septal repair implants, delivery systems and methods for repairing cardiac and vascular defects. We are the exclusive licensee to a patent used in nitinol septal repair devices which expires in 2011. We believe the near expiration of these patents is not likely to have a significant impact on our business. We are also the exclusive licensee under certain patents, expiring from 2014 to 2019, related to the intestinal collagen layer utilized in our BioSTAR® device and under certain patents, expiring from 2010 to 2023, related to the novel bioabsorbable polymer utilized in our BioTREK™ device.

We also rely on trade secrets and technical know-how in the development and manufacture of our devices, which we seek to protect, in part, through confidentiality agreements with our employees, consultants and other parties. We have eight trademarks, four of which are registered with the United States Patent and Trademark Office (see the following table).

savpride.com/wordpress/wp-content/uploads/...cer_animated.gif" style="max-width:560px" />

..wissen wir mehr!

img684.imageshack.us/img684/9887/rocket04june.gif

-/-

Da scheint sich ja die Mannschaft einig zu sein!!! :-)

HiddenGemStocks.com offers a free newsletter on various active stocks on all major exchanges in the U.S.A. and in Canada. To date thousands of our subscribers grow their portfolios daily by using our services. Join us today at HiddenGemStocks.com and watch your account size grow!!!

Disclaimer:

The assembled information disseminated by HiddenGemStocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. HiddenGemStocks.com does expect that investors will buy and sell securities based on information assembled and presented on HiddenGemStocks.com site and/or newsletter. PLEASE always do your own due diligence, and consult your financial advisor.

Contact Information:
hiddengemstocks
Adam Garcia
Tel: 407-405-1474
Email us

http://emailwire.com/release/...MWE-SMOD-NMT-Medical-Inc-HCP-AGU.html

NMT Medical is an advanced medical technology company that designs, develops, manufactures and markets proprietary implant technologies that allow interventional cardiologists to treat structural heart disease through minimally invasive, catheter-based procedures. NMT is currently investigating with its CLOSURE I clinical trial, the potential connection between a common heart defect that allows a right-to-left shunt or flow of blood through a defect like a patent foramen ovale (PFO) and brain attacks such as embolic stroke, transient ischemic attacks (TIAs) and migraine headaches. A common right-to-left shunt can allow venous blood, unfiltered and unmanaged by the lungs, to enter the arterial circulation of the brain, possibly triggering a cerebral event or brain attack. More than 32,000 PFOs have been treated globally with NMT's minimally invasive, catheter-based implant technology.

Stroke is a leading cause of death in the United States and the leading cause of disability in adults. Each year, 750,000 Americans suffer a new or recurrent stroke and an additional 500,000 Americans experience a TIA.

For more information about NMT Medical, please visit cts.businesswire.com/ct/...5=5aedd0bb5d1ba5c47bcc655463a88c1a.

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties or other factors that may cause actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Factors that might cause such a difference include, but are not limited to, those discussed under the heading “Risk Factors” included in the Management's Discussion and Analysis of Financial Condition and Results of Operations in the Company’s Annual Report on Form 10-K for the year ended December 31, 2009, Quarterly Report on Form 10-Q for the period ended March 31, 2010, and subsequent filings with the U.S. Securities and Exchange Commission.



Contact:
NMT Medical, Inc.Richard Davis, 617-737-0930Chief Operating Officer

finance.yahoo.com/news/...apid-bw-2095920926.html?x=0&.v=1

The RT2 Delivery System is available in France. The Company expects to launch the system in countries throughout Europe over the next several months.

investorshub.advfn.com/boards/board.aspx?board_id=12515

messages.finance.yahoo.com/mb/NMTI

www.boardcentral.com/boards/nmti

investorshub.advfn.com/boards/read_msg.aspx?message_id=51495542


LESEN !

www.whalewisdom.com/stock/nmti

www.secform4.com/insider-trading/1017259.htm

images.investorshub.advfn.com/images/...6/20/mleuynmti_hf.jpg" style="max-width:560px" />

16-Feb-10 GLENHILL ADVISORS LLC
Beneficial Owner (10% or more) 761,938 Indirect Purchase at $2.15 per share. $1,638,166

finance.yahoo.com/q/it?s=NMTI+Insider+Transactions

INSIDER TRANSACTIONS REPORTED - LAST TWO YEARS

Date Insider Shares Type Transaction Value* 18-May-10 KRAMER PAUL H. Director 120,716 Direct Statement of Ownership N/A 31-Mar-10 DAVIS RICHARD E Officer 2,747 Direct Acquisition (Non Open Market) at $4.53 per share. $12,443 23-Mar-10 MARTIN FRANCIS J Officer 10,416 Direct Acquisition (Non Open Market) at $4.80 per share. $49,996 23-Mar-10 DAVIS RICHARD E Officer 10,746 Direct Acquisition (Non Open Market) at $4.80 per share. $51,580 3-Mar-10 AHERN JOHN E Director 3,516 Direct Acquisition (Non Open Market) at $2.37 per share. $8,332 16-Feb-10 HANLEY DANIEL F MD Director 10,000 Direct Purchase at $2.15 per share. $21,500 16-Feb-10 MAHONEY JAMES J JR Director 11,650 Direct Purchase at $2.15 per share. $25,047 16-Feb-10 DAVIS RICHARD E Officer 11,650 Direct Purchase at $2.15 per share. $25,047 16-Feb-10 GLENHILL ADVISORS LLC Beneficial Owner (10% or more) 761,938 Indirect Purchase at $2.15 per share. $1,638,166 11-Feb-10 MARTIN FRANCIS J Officer 18,100 Direct Option Exercise at $1.50 - $2 per share. N/A 15-Jan-10 CLARKSON CHERYL L Director 10,000 Direct Acquisition (Non Open Market) at $2.25 per share. $22,500 15-Jan-10 HANLEY DANIEL F MD Director 9,333 Direct Acquisition (Non Open Market) at $2.25 per share. $20,999 15-Jan-10 MARTIN FRANCIS J Officer 4,048 Direct Acquisition (Non Open Market) at $2.25 per share. $9,108 15-Jan-10 MAHONEY JAMES J JR Director 12,222 Direct Acquisition (Non Open Market) at $2.25 per share. $27,499 15-Jan-10 DAVIS RICHARD E Officer 5,532 Direct Acquisition (Non Open Market) at $2.25 per share. $12,447

Ich denke da werden einige nochmal nachlegen zu den Preisen nach dem Panik selloff..

Interessante Meinung !

http://messages.finance.yahoo.com/...=11065&tof=1&frt=2#11065

 

Re: MASSIVE Insider buys betwen $2 and $5:     14 minutes ago    

Also der Aktienpreis ist sehr Verlockend hier..sozusagen ein Schnäppchen, denke das wird sich sehr schnell ausbezahlen das Investment. Bin schon ganz gespannt was morgen passiert. ITMN ist ja in aller Munde , im IHUB , Yahoo usw usw...viele Augen aber wenig Aktien !!! 

Ob das so schnell raufgeht wie es runterging ??

 

bildschirmarbeiter.com/content/anigifs/...ated-gifs-26-06.gif" style="max-width:560px" />

mcaaron.files.wordpress.com/2009/10/bounce.jpg" style="max-width:560px" />

Ihr werdet sehen !

circles.globe.com.ph/mobile/files/2009/01/bounce.jpg" style="max-width:560px" />

NMTI DD highlights:
From Yahoo
messages.finance.yahoo.com/...mp;mid=11091&tof=1&frt=2

www.nmtmedical.com/

www.closurei.com/

Die Aktie kommt von ca. 5$ und hat bei ca. 50cent (alltime low) aufgeschlagen ! (Überreaktion)
Wird nicht lange unter 1$ zu haben sein...vielleicht schon heute nicht mehr.
Bei nur 7 mill handelbaren Aktien kann das ganz schnell gehen, ich deke am Freitag wurden ziemlich viele Fake-Shares gehandelt, und bei dem regen Interesse müssen die MM's das wieder in den Griff bekommen...
Werden Insider/institutionelle bei diesem Preis nachkaufen ? :-)

Warten auf die Ami's !

...so jetzt kommen auch bald die Ami's...noch 3 Stunden...

realtime.bigcharts.com/...tyle=2003&size=1&mocktick=1" style="max-width:560px" />

Premarket tut sich schon etwas !

www.nasdaq.com/aspxcontent/...I&symbol=ABK&symbol=YHOO

14minuten !

Nmt Medical Inc. (MM (NASDAQ:NMTI)
Last Price (USD) $0.8007
Change  0.0719 (9.87%)
Bid 0.8008
Ask 0.8009
Volume 316,359
Days Range 0.75 - 0.81
Last Trade 6/21/2010 9:34:10 AM

scheint das gap von heute morgen wird erst mal geschlossen...

Nmt Medical Inc. (MM (NASDAQ:NMTI)
Last Price (USD) $0.7693
Change  0.0405 (5.56%)
Bid 0.7651
Ask 0.7691
Volume 1,451,707
Days Range 0.74 - 0.8282
Last Trade 6/21/2010 11:50:25 AM

sieht aus als ob wir die Rakete heute gg. ne Konso eintauschen ...naja, alles zu seiner Zeit ;).

lesen..mit Intraday chart !

investorshub.advfn.com/boards/read_msg.aspx?message_id=51540061

realtime.bigcharts.com/...tyle=2003&size=1&mocktick=1" style="max-width:560px" />

investorshub.advfn.com/boards/read_msg.aspx?message_id=51540801

investorshub.advfn.com/boards/...id=51554168&txt2find=nmti

Yes just as you posted i was reading the 13G and watched if its listed at www.insidercow.com
Sellers should be out now. IMO !



S 2010-06-18 2010-06-22 17:26:01 NMT MEDICAL INC NMTI GLENHILL CAPITAL MANAGEMENT LL various various 10% owner 341,938 $0.69 $236,963.00 1,127,420 view
S 2010-06-18 2010-06-22 17:26:01 NMT MEDICAL INC NMTI GLENHILL CAPITAL MANAGEMENT LL various various 10% owner 240,000 $0.65 $156,000.00 1,469,360 view
S 2010-06-18 2010-06-22 17:26:01 NMT MEDICAL INC NMTI GLENHILL CAPITAL MANAGEMENT LL various various 10% owner 400,000 $0.68 $271,760.00 1,709,360 view
S 2010-06-18 2010-06-22 17:26:01 NMT MEDICAL INC NMTI GLENHILL CAPITAL MANAGEMENT LL various various 10% owner 500,000 $0.76 $382,300.00 2,109,360 view

Looks like they are done...

Glenhill Capital, LP

(d) The Reporting Persons no longer own any Common Stock of the Issuer.

ih.advfn.com/p.php?pid=nmona&article=43343166


June 18, 2010 Sold 239,940

191,900

115,200

479,700

164,138 $0.7646

$0.6794

$0.6500

$0.7126

$0.6930

Glenhill Concentrated Long Master Fund, LLC June 18, 2010 Sold 47,300

37,900

22,700

94,700

32,400 $0.7646

$0.6794

$0.6500

$0.7126

$0.6930

Glenhill Capital Overseas Master Fund, LP June 18, 2010 Sold 212,760

170,200

102,100

425,600

145,400
$0.7646

$0.6794

$0.6500

$0.7126

$0.6930

Glenn J. Krevlin June 18, 2010 Sold 118,420 $0.7110

Glenn J. Krevlin June 21, 2010 Sold 300

8,700 $0.8001

$0.8000



(d) The Reporting Persons no longer own any Common Stock of the Issuer.

Afterhours 0.74$  da tut sich was. :-)

investorshub.advfn.com/boards/read_msg.aspx?message_id=51675563

Posted by: jaybird249    Date: Thursday, June 24, 2010 3:23:24 PM  
In reply to: None  Post # of 1888288      

NMTI:NASDAQ green, double bottom in. Going to explode to $1 ++
finance.yahoo.com/...s?s=NMTI+Interactive#symbol=NMTI;range=5d

NMTI declined 400% last week, an absurd overreaction to PRELIMINARY results that were OVERALL POSITIVE:

-STARFlex provided SMALL BENEFIT OVER CURRENT BEST MEDICAL THERAPY and maintained an excellent safety profile. NMTI is discussing next steps with the FDA.

Other useful DD and links:

-NMTI dramatically oversold:
messages.finance.yahoo.com/Stocks...

-55% of float owned by institutions. "Available float" only 7 million shares.

-Insiders have purchased over 800,000 shares at prices over $2 in last 6 months.

-The most successful U.S. hedge fund- Renaissance Technololgies, owns NMTI. Renaissance has an army of engineers and MBA's scouring for undervalued stocks.

-In may, the NMTI RT2 Delivery System was lauched in France and will be launched all throughout Europe over the next few months.
finance.yahoo.com/news/NMT-Medica...

-NMTI Owns or licenses 136 patents, relating to structural heart repair implant technologies and other related cardiovascular implant technologies.

:-)

mcaaron.files.wordpress.com/2009/10/bounce.jpg" style="max-width:560px" />

und bis weihnachten auch wieder über 1 US$

realtime.bigcharts.com/...tyle=2003&size=1&mocktick=1" style="max-width:560px" />

investorshub.advfn.com/boards/read_msg.aspx?message_id=58169748

www.mysmartrend.com/news-briefs/...ard-momentum-shares-nmt-med

SmarTrend's Trend Spotter See Continued Upward Momentum on Shares of NMT Medical (NMTI)
Written on Mon, 01/03/2011 - 10:03am
By Chip Brian

SmarTrend is monitoring the recent change of momentum in NMT Medical. Please refer to our Company Overview for the results of our proprietary technical indicators that have been scanning shares of NMT Medical in search of a potential trend change.
In the past 52 weeks, shares of NMT Medical have traded between a low of $0.20 and a high of $4.99 and are now at $0.42, which is 109% above that low price.
NMT Medical is currently above its 50-day moving average of $0.28 and should find resistance at its 200-day moving average of $1.43. Look for these moving averages to climb to confirm the company's upward momentum.
In the last five trading sessions, the 50-day MA has fallen 0.56% while the 200-day MA has slid 5.21%.
SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of NMT Medical shares.

NMT Medical Announces New $2 Million Credit Facility

Date : 01/06/2011 @ 7:30AM
Source : MarketWire
Stock : NMT Medical (NMTI)

ih.advfn.com/p.php?pid=nmona&article=45903874

NMT Medical, Inc. (NASDAQ: NMTI) today announced that it has entered into a credit agreement with LSQ Funding Group, L.C., a Florida-based firm that specializes in providing financing to small- and medium-sized businesses.

The asset-based credit facility provides for borrowings up to $2 million for working capital requirements and other general corporate purposes. The credit facility has a one-year term and is subject to a borrowing base calculated as a percentage of domestic accounts receivable that are pledged as collateral against the loan.

Richard E. Davis, NMT's Chairman, President and Chief Executive Officer, said, "This non-equity based credit facility, which replaces the credit arrangement with Silicon Valley Bank that we recently terminated, provides NMT with the necessary working capital required to fund its ongoing operations. We continue to tightly manage our expenses while working closely with the U.S. Food and Drug Administration to evaluate our potential next steps relating to patent foramen ovale (PFO) treatment for the stroke and transient ischemic attack (TIA) indications. In addition, we are continuing to evaluate all strategic options."

http://www.ariva.de/_t72764?pnr=9400082#jump9400082

0.9 schon mal um die "Ecke"